Special Issue "Development and Adaptation of New and Better Pediatric Drugs"
Deadline for manuscript submissions: closed (30 June 2021).
Interests: oral dosage forms; design and control; quality control; pediatrics medicines; drugs 3D printing
The combination of incentives and requirements established in recent years by drug regulatory agencies has allowed an increase in the quality, safety, and efficacy of medicines used in Pediatrics. However, this has not been sufficient and today, more than half of children are prescribed medicines whose posology is intended for an adult and which are not authorized for children, in the absence of a dosage form suitable for them. The absence of marketed medicines that meet the therapeutic needs of newborns or young children, mainly as regards the magnitude of the dose, pharmaceutical dosage form, and acceptance of the patient, justifies the individualization of treatments at different levels of care.
This Special Issue includes different alternatives for the development and adaptation of pharmacological treatments for pediatrics that come to cover therapeutic gaps because the drug does not exist with the proper dose or pharmaceutical dosage form and with the proper guarantees of quality, efficacy, and safety.
Prof. Dr. José B. Fariña
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- adapted formulation
- quality control
- dosage forms
- dose uniformity